Drugs / LNF2007
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06752447 | Jan 2025 → Dec 2026 expected | — | Shandong New Time Pharmaceutical Co., LTD | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LNF2007 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06752447 ↗ |
| Route | Intravenous | “IV, infusion time 60min±10min” NCT06752447 ↗ |